Jamie Heywood

Working on what's next. Founder, Former Chairman & CEO of PatientsLikeMe, AOBiome & ALS TDI. Co-Founder of iCarbonX, Genetic Networks & The SocialMedwork. Board Member of ICHOM

Newton, MA

How does this work?
Work experience

Oct 2020 - Present

Harvard Medical School and Massachusetts General Hospital

Advisory Council Member Center for the Neuroscience of Psychedelics

Advisory Council Member Center for the Neuroscience of Psychedelics. The Center seeks to understand how psychedelics enhance the brain’s capacity for change, optimize current treatments and create new treatments for mental illness, and make the term “treatment-resistant” obsolete.


Aug 2020 - Present

Alden Scientific

Founder & Chairman

First-Principal-Based Digital Biology

Aug 2019 - Present

International Consortium for Health Outcomes Measurement (ICHOM)

Board Member

At ICHOM, we’re developing a new paradigm focused on health outcomes – the results that matter most to patients. The end result? A world where patients ask their doctors about meaningful outcomes, and doctors can respond with data-driven answers.


Jun 2015 - Present

Genetic Networks


A new paradigm for lead discovery and optimization through the analysis of functional Genetic Network Output Signatures (GNOS)


Jan 2015 - Present


Co-Founder & Board Member

Advocate and supporter of Sjaak Vink, CEO & Founder of The Social Medwork and their entire team who are working to build a patient-centered vision of ethical, easy, early access to promising medicines and diagnostics worldwide.


Aug 2012 - Present


Co-Founder & Board Member, Former CEO and Chairman

AOBiome is a Cambridge, MA based biotech company working on the science of Ammonia Oxidizing Bacteria (AOB) and human health. AoBiome does primary research, collaborates with others on research, and develops applications to positively impact skin conditions and reduce systemic inflammation.

Apr 2010 - Present

Leigh Bureau (IRL) Ltd.


The Leigh Bureau is a premium speakers bureau serving business and sophisticated cultural audiences worldwide.

Jan 1999 - Present

ALS Therapy Development Institute

Founder, Board Member, Former CEO & Chairman

I founded ALS TDI in 1999 when my brother, Stephen, was diagnosed with ALS. I served as CEO until August 2007 and remain an active Board member and supporter. ALS TDI is the world's first non-profit biotechnology company and operates a dedicated 25,000 ft research facility in Cambridge, MA. It is committed to developing effective treatments for ALS and remains the world's leading ALS research program.


2005 - Nov 2019


Co-Founder, Chairman, CEO

PatientsLikeMe is a patient network that improves lives and serves as a real-time research platform that advances medicine. On PatientsLikeMe’s network, people connect with others who have the same disease or condition and track and share their own experiences. In the process, they generate data about the real-world nature of disease that helps researchers, pharmaceutical companies, regulators, providers and nonprofits to develop more effective products, services and care.


Apr 2018 - Jun 2019


Co-Founder of iCarbonX international, Chief Research Officer

Chief Research Officer. Jamie oversees iCarbonX’s research activities, including data sciences and the iCX Research Institute, and is a member of the Board of Directors. iCarbonX Group includes iCarbonX, PatientsLikeMe & HealthTell and is building a global consumer ecosystem to digitize life and provide services and products to improve health, disease, and aging.

Aug 2011 - Oct 2016

National Academy of Medicine

Leadership Consortium for Value & Science-Driven Health Care

The Leadership Consortium for Value & Science-Driven Health Care is comprised of senior leaders and innovative members whose organizations work collaboratively through the National Academy of Medicine in advancing progress toward a continuously learning health system, care that is more efficient and effective, and better health for Americans.


Jun 2011 - Dec 2013


Board of Advisors

Member of the advisory board of TEDMED, supporting its mission to re-imagine and promote the future of health and medicine.


Aug 2008 - Dec 2011

Centers for Disease Control and Prevention

Member, National Biosurveillance Advisory Subcommitee & Head of the innovation working group

The CDC established the National Biosurveillance Advisory Subcommittee (NBAS) in May of 2008 as a subcommittee to the Advisory Committee to the Director (ACD), CDC. As a subcommittee to the ACD, the NBAS provides counsel to the federal government through the ACD regarding the broad range of issues impacting the development and implementation of a nationwide biosurveillance strategy for human health. The committee produced two reports: Improving the Nation’s Ability to Detect and Respond to 21st Century Urgent Health Threats: First Report: http://www.cdc.gov/osels/pdf/NBAS%20Report%20-%20Oct%202009.pdf Second Report: http://www.cdc.gov/about/pdf/advisory/nbasfinalreport_april2011.pdf

Jan 1998 - Mar 1999

The Neurosciences Institute

Director of Technology Development


1991 - Jan 1998

Advent Design Corp.

Director of Product Development

1990 - 1991




1988 - 1991

SB, Mechanical Engineering

Talk to Jamie

@ Copyright 2020 OfficeHours Technologies Co.